A clinical study of liuzijue qigong to improve cancer-related depressio
- Conditions
- Cancer-related Depression
- Registration Number
- ITMCTR2100004728
- Lead Sponsor
- Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Clinically or pathologically diagnosed as malignant tumor, depression is related to the diagnosis or treatment of tumor;
2.The (SDS) standard score of self-rating depression scale was >= 50;
3.Physical fitness score (ECOG PS) <= 2;
4.The thinking, reading and discriminating ability of the patients were normal, and they could sign the informed consent form.
Note: the cut-off value of SDS is 50, and the depression is judged. According to the different scores, the mild, moderate and severe scores are 50-59, 60-69 and > 70, respectively, and the mild score is 50-59, the moderate score is 60-69, and the severe score is more than 70. Among them, patients with moderate and severe depression, according to the wishes of the patients and their families, decide whether to go to psychiatry for diagnosis and evaluation immediately, and draw up an antidepressant treatment plan according to the advice of psychiatrists.
1.It was diagnosed as organic mental disorder and primary sleep disorder;
2.In addition to anxiety and depression, complicated with other mental symptoms or history of mental disorders;
3.Those who suffer from knee joint or cervicolumbar disease can not stand for a long time;
4.Coughing frequently due to cold, wind or chest surgery, and can not tolerate deep breathing.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Human cytochrome P4502D6;5-hydroxytryptamine;Dopamine;Self-Rating Depression Scale;Melatonin;
- Secondary Outcome Measures
Name Time Method ECOG score;Clinical syndrome score of Traditional Chinese medicine;Interleukin-6;Cancer patient quality of life scale;PSQI;CD4+;CD4+/CD8+;Homocysteine;Tumor necrosis factor-a;Interleukin-2 receptor;CD8+;